[HTML] frontiersin.org

[HTML][HTML] Utilization of CRISPR-mediated tools for studying functional genomics in hematological malignancies: an overview on the current perspectives, challenges …

M Solayappan, A Azlan, KZ Khor, NM Yusoff… - Frontiers in …, 2022 - frontiersin.org
Hematological malignancies (HM) are a group of neoplastic diseases that are usually
heterogenous in nature due to the complex underlying genetic aberrations in which …
被引用次数：2 相关文章
[PDF] academia.edu

[PDF][PDF] Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges …

M Solayappan, A Azlan, KZ Khor, MY Yik… - Front. Genet. 12 …, 2022 - academia.edu
Hematological malignancies (HM) are a group of neoplastic diseases that are usually
heterogenous in nature due to the complex underlying genetic aberrations in which …

Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and …

M Solayappan, A Azlan, KZ Khor, MY Yik… - Frontiers in …, 2022 - europepmc.org
Hematological malignancies (HM) are a group of neoplastic diseases that are usually
heterogenous in nature due to the complex underlying genetic aberrations in which …
[HTML] frontiersin.org

[HTML][HTML] Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives …

M Solayappan, A Azlan, KZ Khor, NM Yusoff… - Frontiers in …, 2022 - frontiersin.org
Hematological malignancies (HM) are a group of neoplastic diseases that are usually
heterogenous in nature due to the complex underlying genetic aberrations in which …
[HTML] nih.gov

[HTML][HTML] Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives …

M Solayappan, A Azlan, KZ Khor, MY Yik… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Hematological malignancies (HM) are a group of neoplastic diseases that are usually
heterogenous in nature due to the complex underlying genetic aberrations in which …

Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and …

M Solayappan, A Azlan, KZ Khor… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Hematological malignancies (HM) are a group of neoplastic diseases that are usually
heterogenous in nature due to the complex underlying genetic aberrations in which …

Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and …

M Solayappan, A Azlan, KZ Khor, MY Yik… - Frontiers in …, 2022 - europepmc.org
Hematological malignancies (HM) are a group of neoplastic diseases that are usually
heterogenous in nature due to the complex underlying genetic aberrations in which …